Main Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit <a href=http://www.fda.gov/AdvisoryCommittees/default.htm>http://www.fda.gov/AdvisoryCommittees/default.htm</a> <i>Information is current as of December 31, 2012.</i> Percent Vacant Positions line 0 0

Oct 2009 10 33 Nov 2009 10 36 Dec 2009 10 Jan 2010 10 Feb 2010 10 35 Mar 2010 10 36 Apr 2010 10 34 May 2010 10 33 Jun 2010 10 31 Jul 2010 10 35 Aug 2010 10 29 Sep 2010 10 26 0

Oct 2010 10 25 Nov 2010 10 23 Dec 2010 10 23 Jan 2011 10 25 Feb 2011 10 23 Mar 2011 10 23 Apr 2011 10 22 May 2011 10 20 Jun 2011 10 20 Jul 2011 10 23 Aug 2011 10 21 Sep 2011 10 20 0

Oct 2011 10 19 Nov 2011 10 24 Dec 2011 10 22 Jan 2012 10 23 Feb 2012 10 20 Mar 2012 10 19 Apr 2012 10 17 May 2012 10 17 Jun 2012 10 18 Jul 2012 10 22 Aug 2012 10 22 Sep 2012 10 22

FY 2013 YTD: 6%

Oct 2012 10 20 Nov 2012 10 20 Dec 2012 10 20 Jan 2013 10 Feb 2013 10 Mar 2013 10 Apr 2013 10 May 2013 10 Jun 2013 10 Jul 2013 10 Aug 2013 10 Sep 2013 10 // sub measure oneSubPercent of FDA advisory committee member positions vacant at the end of the monthVacant Positionsline06500

Oct 2009199Nov 2009219Dec 2009Jan 2010Feb 2010213Mar 2010216Apr 2010209May 2010199Jun 2010189Jul 2010210Aug 2010177Sep 20101570650

Oct 2010155Nov 2010141Dec 2010140Jan 2011151Feb 2011139Mar 2011138Apr 2011133May 2011121Jun 2011120Jul 2011139Aug 2011130Sep 20111240

Oct 2011118Nov 2011149Dec 2011137Jan 2012145Feb 2012126Mar 2012120Apr 2012110May 2012106Jun 2012117Jul 2012141Aug 2012137Sep 2012137

Oct 2012 126 Nov 2012 124 Dec 2012 129 Jan 2013 Feb 2013 Mar 2013 Apr 2013 May 2013 Jun 2013 Jul 2013 Aug 2013 Sep 2013 // sub measure twoSubPercent of FDA advisory committee member positions vacant at the end of the monthPositionsline00650

Oct 2009608Nov 2009608Dec 2009Jan 2010Feb 2010608Mar 2010608Apr 2010608May 2010608Jun 2010608Jul 2010608Aug 2010608Sep 20106080650

Oct 2010608Nov 2010608Dec 2010608Jan 2011608Feb 2011608Mar 2011608Apr 2011608May 2011608Jun 2011608Jul 2011608Aug 2011621Sep 20116210

Oct 2011621Nov 2011621Dec 2011621Jan 2012621Feb 2012621Mar 2012621Apr 2012634May 2012634Jun 2012634Jul 2012634Aug 2012634Sep 2012634

Oct 2012 634 Nov 2012 634 Dec 2012 634 Jan 2013 Feb 2013 Mar 2013 Apr 2013 May 2013 Jun 2013 Jul 2013 Aug 2013 Sep 2013 http://www.fda.gov/AboutFDA/Transparency/track/ucm216403.htmFDA-TRACK Advisory Committees Dashboard਍††਍਍਍਍਍਍਍